Pricing
Five things for pharma marketers to know: Wednesday, June 21, 2017
June 21, 2017Insurance companies balk at expensive PCSK9 inhibitors; Publicis to focus investments on AI platform; clinical trial reveals Novartis' eye drug requires less frequent injections
Five things for pharma marketers to know: Friday, June 16, 2017
June 16, 2017Apple reportedly working to bring EMRs to iPhone; FDA to study disclosures in ads; Trump admin discussing drug price EO
Five things for pharma marketers to know: Friday, June 9, 2017
June 09, 2017The FDA asks Endo to take opioid off the market; Lilly partners with Swiss biotech; House committee advances PDUFA bill — without off-label provision
Physicians call for DTC ads to include retail prices
June 05, 2017They are asking the American Medical Association to support the policy proposal.
Five things for pharma marketers to know: Monday, June 5, 2017
June 05, 2017Medicare beneficiaries struggle to pay for COPD inhalers; Novartis partners with IBM Watson Health; Mylan hasn't lowered EpiPen prices
Five things for pharma marketers to know: Thursday, June 1, 2017
June 01, 201750% of consumers say they will share their health data with tech giants; pharma CEOs expect pricing proposal from Trump administration; FDA approves generic versions of Strattera
Keep Calm and Sell Drugs: Your New Daily Affirmation?
June 01, 2017To be sure, anything borrowing from the well-known "Keep Calm" genre should not be construed as advice. The doctor is definitely not in.
In Surprising Twist, Trust Rises for Healthcare Companies
May 23, 2017But will pharma and biotechnology firms be able to advance this year's positive momentum?
Five things for pharma marketers to know: Tuesday, May 9, 2017
May 09, 2017Sanofi ties price increases to growth rate; Regeneron to target 7,000 docs on new eczema drug Dupixent; NIH and biotech execs meet White House officials
Five things for pharma marketers to know: Monday, May 8, 2017
May 08, 2017Pfizer to provide Ibrance for free during NICE analysis; the FDA approves new ALS drug; people turn to Twitter to tell stories about pre-existing conditions
Five things for pharma marketers to know: Thursday, May 4, 2017
May 04, 2017Louisiana may use 1910 law to discount hep-C drugs; House bill would reduce coverage for 24 million people; drugmakers pursue pay-for-performance deals
U.S. drug spend grew by 6% in 2016, the lowest rate in two years
May 04, 2017This is likely due to fewer product launches and lower price increases.
Five things for pharma marketers to know: Wednesday, May, 3, 2017
May 03, 2017Teaching hospitals that limit detailing prescribe fewer branded drugs; new ad campaign criticizes drug pricing; Ad Age reports healthcare is fastest growing agency discipline
Pharma Execs Can Do More to Address Industry's Reputation
April 26, 2017Some leaders have stepped up, and this serves their companies - and the industry - well.
Five things for pharma marketers to know: Thursday, April 20, 2017
April 20, 2017Tesaro discloses price for new drug that differs from FDA-approved dosage; uniQure discontinues Glybera; O'Reilly leaves Fox
Five things for pharma marketers to know: Tuesday, April 11, 2017
April 11, 2017Groups with PhRMA ties warn against drug-pricing proposals; patients learn how to be advocates; the U.K. will not cover Opdivo for head and neck cancer
Five things for pharma marketers to know: Friday, March 17, 2017
March 17, 2017The FDA delays final rule related to off-label use; Amgen's Repatha reduces risk of death by 20%, study finds; FDA rejects AstraZeneca's hyperkalaemia drug
Five things for pharma marketers to know: Thursday, March 16, 2017
March 16, 2017Marathon to sell Emflaza to PTC Therapeutics; Emma Walmsley's salary is lower than Andrew Witty's; Trump considers Medicare negotiation of drug prices
Five things for pharma marketers to know: Tuesday, March 14, 2017
March 14, 2017Pershing Square sells entire Valeant stake; FDA approves Novartis breast-cancer drug combo; Express Scripts asks Gilead to lower hep-C drug prices
Five things for pharma marketers to know: Wednesday, March 8, 2017
March 08, 2017Researchers question relationship between R&D costs and drug prices; Alexa uses WebMD to answer health questions; lawmakers push GAO to investigate orphan drugs
Five things for pharma marketers to know: Monday, March 6, 2017
March 06, 2017Gilead exec blames PBMs for high drug prices; Google uses AI to detect signs of breast cancer; Sanofi and Regeneron drug effective in treating eczema
Five things for pharma marketers to know: Thursday, March 2, 2017
March 02, 2017Ten drugmakers seek to exclude pricing information from proxy ballots; roughly 85% of patient advocacy groups get industry funding; Juno halts lead CAR-T project
Five things for pharma marketers to know: Wednesday, March 1, 2017
March 01, 2017Trump reiterates call to bring down drug prices; Novartis renews its focus on immunotherapies; a new bill would allow drugs to be imported
Five things for pharma marketers to know: Tuesday, February 28, 2017
February 28, 2017J&J discloses list prices for its drugs; Kite's CAR-T therapy meets study goals; healthcare providers seek to engage patients in decisionmaking
Top 25 rare disease brands, by sales
February 15, 2017Teva Pharmaceutical Industries' Copaxone is by far the top-selling drug, bringing in $3.2 billion in U.S. sales in 2015.
On drug pricing, Acorda CEO is optimistic
February 15, 2017Acorda CEO Ron Cohen applauded Marathon's move to pause the commercial activities for its new DMD drug.
Three kinds of drugs, like those that treat RA and diabetes, drive increase in spending
February 08, 2017Spending for inflammatory drugs like AbbVie's Humira and Amgen's Enbrel rose, while hepatitis C drugs showed decline.
Five things for pharma marketers to know: Monday, February 6, 2017
February 06, 2017Novo Nordisk CEO describes 'volatile' pricing environment; Lilly to cut 200 research and development jobs; pharma opts out of Super Bowl this year
It's Time for Trump to Make Good on his Drug Pricing Promises
February 06, 2017Last week President Trump told drugmakers that 'the pricing has been astronomical.'
MM&M's top 5 stories in January 2017
February 01, 2017Merck and Aetna partner in value-based drug pricing; data scientists rising in the biopharma ranks; Japanese pharma leads digital health innovation
